Metastatic Lung Cancer Clinical Trials

49 clinical trials for Metastatic Lung Cancer across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety and Efficacy of OBX-115 in Advanced Solid Tumors — RECRUITING · PHASE1
• Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies — RECRUITING · PHASE1
• A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer — RECRUITING · PHASE1
• Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study) — RECRUITING
• Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients — RECRUITING · NA
• Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway — RECRUITING
• LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG — RECRUITING · NA
• Definitive Radiation for High-Risk Spine Metastases — RECRUITING · PHASE2
• Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• The Impact of Radiotherapy on Oligometastatic Cancer — RECRUITING
• Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients — RECRUITING · PHASE2
• Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer — RECRUITING · PHASE2
• Effects of Infusion Timing on Treatment Response in Solid Tumors — NOT_YET_RECRUITING · PHASE2
• Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations — ACTIVE_NOT_RECRUITING · PHASE1
• Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Exercise as Maintenance Therapy in Advanced Lung Cancer — TERMINATED · NA
• A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer — COMPLETED · NA
• A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer — NOT_YET_RECRUITING · PHASE1
• Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC — COMPLETED · PHASE1
• Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases — ACTIVE_NOT_RECRUITING · NA
• Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• CALM: Managing Distress in Malignant Brain Cancer — COMPLETED · NA
• Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer — COMPLETED · NA
• Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer — COMPLETED · PHASE3
• Vapor Ablation for Localized Cancer Lesions — NOT_YET_RECRUITING · NA
• (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations — TERMINATED · PHASE1
• Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer — NOT_YET_RECRUITING · PHASE1
• INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 — WITHDRAWN · PHASE2
• Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases — TERMINATED · PHASE1
• Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study — COMPLETED
• Piloting Pathways With Lung Cancer Patients — COMPLETED · NA
• Emulation of the KEYNOTE-189 Trial Using Electronic Health Records — COMPLETED
• Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) — COMPLETED · PHASE2
• A Study to Assess PV-10 Chemoablation of Cancer of the Liver — OTHER · PHASE1
• Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects — COMPLETED · PHASE1
• Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) — COMPLETED · NA
• Safety and Efficacy of Cryoablation for Metastatic Lung Tumors — COMPLETED · NA
• DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria — OTHER · NA
• Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC — COMPLETED · PHASE2
• A Study of ASN007 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease — TERMINATED · PHASE2
• A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations — TERMINATED · PHASE2
• Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously — COMPLETED · PHASE1
• McMaster Catheterization for Thoracoscopic Surgery Study — WITHDRAWN · NA
• Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers — TERMINATED
• The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel — OTHER

Refine this search